Outcomes measures in a decade of dementia and mild cognitive impairment trials

Alzheimer's Research and Therapy

Volumn 8, Issue 1, 2016, Pages 1-10

  Harrison, Jennifer Kirsty ^a   Noel Storr, Anna H ^b   Demeyere, Nele ^c   Reynish, Emma L ^d   Quinn, Terry J ^e  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF STIRLING   (United Kingdom)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Behaviour; Cognition; Dementia; Function; Measurement; Mood; Outcome; Patient centred; Quality of life

Indexed keywords

ARTICLE; BEHAVIOR; COGNITION; DEMENTIA; DISEASE SEVERITY; FUNCTIONAL STATUS; HUMAN; INSTITUTIONALIZATION; MEDICAL RECORD; MILD COGNITIVE IMPAIRMENT; MOOD; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; COGNITIVE DYSFUNCTION; NEUROPSYCHOLOGICAL TEST;

COGNITIVE DYSFUNCTION; DEMENTIA; HUMANS; NEUROPSYCHOLOGICAL TESTS; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 84995542999     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/s13195-016-0216-8     Document Type: Article

References (34)

1. Hobart J, Cano S, Zajicek J, Thompson A. Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations. Lancet Neurol. 2007;6:1904-105.
2. Naik M, Nygaard H. Diagnosing dementia - ICD-10 not so bad after all: a comparison between dementia criteria according to DSM-IV and ICD-10. Int J Geriatr Psychiatry. 2008;23:279-82.
3. Wancata J, Börjesson-Hanson A, Ostling S, Sjögren K, Skoog I. Diagnostic criteria influence dementia prevalence. Am J Geriatr Psychiatry. 2007;15:1034-45.
4. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Press; 1994.
5. Noel-Storr A, Flicker L, Ritchie C, Nguyen G, Gupta T, Wood P, et al. Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementia. Alzheimers Dement. 2013;9:e96-105.
6. Svensson S, Menkes D, Lexchin J. Surrogate outcomes in clinical trials: a cautionary tale. JAMA Intern Med. 2013;173:611-2.
7. Bossers W, van der Woude L, Boersma F, Scherder E, van Heuvelen M. Recommended measures for the assessment of cognitive and physical performance in older patients with dementia: a systematic review. Dement Geriatr Cogn Disord Extra. 2012;2:589-609.
8. Lees R, Fearon P, Harrison J, Broomfield N, Quinn T. Cognitive and mood assessment in stroke research: focused review of contemporary studies. Stroke. 2012;43:1678-80.
9. Petersen R. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256:183-94.
10. Hill J, Fillit H, Thomas SK, Chang S. Functional impairment, healthcare costs and the prevalence of institutionalisation in patients with Alzheimer's disease and other dementias. Pharmacoeconomics. 2006;24:265-80.
11. World Health Organization (WHO). International classification of functioning, disability and health (ICF). Geneva: WHO; 2001.
12. Katona C, Livingston G, Cooper C, Ames D, Brodaty H, Chiu E, on behalf of the Consensus Group. International Psychogeriatric Association consensus statement on defining and measuring treatment benefits in dementia. Int Psychogeriatr. 2007;19:345-54.
13. U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER). Guidance for industry: Alzheimer's disease: developing drugs for the treatment of early stage disease. Silver Spring, MD: U.S. Department of Health and Human Services; February 2013. http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm338287.pdf. Accessed 9 Aug 2016.
14. Ready RE, Ott BR. Quality of life measures for dementia. Health Qual Life Outcome. 2003;1:11.
15. Quinn TJ, Dawson J, Walters MR, Lees KR. Functional outcome measures in contemporary stroke trials. Int J Stroke. 2009;4:200-5.
16. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. PLoS Med. 2009;6, e1000097.
17. Research Registry. http://www.researchregistry.com/browse-the-registry.html#registryofsystematicreviewsmeta-analyses/. Accessed 27 June 2016.
18. ALOIS: a comprehensive register of dementia studies. http://www.medicine.ox.ac.uk/alois/. Accessed 15 May 2015.
19. About ALOIS. ALOIS: a comprehensive register of dementia studies. http://www.medicine.ox.ac.uk/alois/content/about-alois. Accessed 18 June 2016.
20. Folstein M, Folstein S, McHugh P. "Mini-mental state" a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-98.
21. Mahoney F, Barthel D. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61-5.
22. Quinn T, Langhorne P, Stott DJ. Barthel Index for stroke trials: development, properties, and application. Stroke. 2011;42:1146-51.
23. Verbeek H, Meyer G, Challis D, Zabalegui A, Soto ME, Saks K, et al. Inter-country exploration of factors associated with admission to long-term institutional dementia care: evidence from the RightTimePlaceCare study. J Adv Nurs. 2015;71:1338-50.
24. The International Consortium for Health Outcomes Measurement (ICHOM). http://www.ichom.org/. Accessed 7 Mar 2016.
25. COMET Initiative. The development of a dementia core outcome set for dementia care in the community. http://www.comet-initiative.org/studies/details/677. Accessed 7 Mar 2016.
26. Slotkin J, Kallen M, Griffith J, Magasi S, Salsman H, Nowinski C, et al. NIH toolbox technical manual. Bethesda, MD: National Institutes of Health; 2012.
27. The International Consortium for Health Outcomes Measurement (ICHOM). Dementia. http://www.ichom.org/medical-conditions/dementia/. Accessed 7 Mar 2016.
28. Ioannidis JP, Greenland S, Hlatky MA, Khoury MJ, Macleod MR, Moher D, et al. Increasing value and reducing waste in research design, conduct, and analysis. Lancet. 2014;383:166-75.
29. Demeyere N, Riddoch M, Slavkova E, Bickerton W, Humphreys G. The Oxford Cognitive Screen (OCS): validation of a stroke-specific short cognitive screening tool. Psychol Assess. 2015;27:883-94.
30. Hsieh S, Schubert S, Hoon C, Mioshi E, Hodges JR. Validation of the Addenbrooke's Cognitive Examination III in frontotemporal dementia and Alzheimer's disease. Dement Geriatr Cogn Disord. 2013;36:242-50.
31. Nelson EC, Eftimovska E, Lind C, Hager A, Wasson JH, Lindblad S. Patient reported outcome measures in practice. BMJ. 2015;350:g7818.
32. Jones CW, Handler L, Crowell KE, Keil LG, Weaver MA, Platts-Mills TF. Non-publication of large randomized clinical trials: cross sectional analysis. BMJ. 2013;347:f6104.
33. Scherer RW, Langenberg P, Von Elm E. Full publication of results initially presented in abstracts. Cochrane Database Syst Rev. 2007;(2):MR000005
34. Schulz K, Altman D, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;152:726-32.